tirzepatide and hypertension blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial Tirzepatide Blood Pressure Reduction: Clinical

PLoS One, 11 (1), Article e0145838

This program will only be available for a limited time (until the FDA removes Wegovy from the shortage list), however while it is available patients can achieve excellent results with an out-of-pocket cost around 80% than for brand name Wegovy

Discover the best clinics, benefits, and expert guidance on achieving sustainable weight loss

Monitor for Warning Signs Even with precautions, problems can arise

Clinical studies show tirzepatide leads to significant weight loss, with participants typically experiencing a 15% or greater decrease in body weight when used alongside dietary and physical activity changes, outperforming similar medications like semaglutide and liraglutide